Wahi a ka hōʻike a FMI, ʻo nā koho no ka mālama ʻana he mau lāʻau anti-rheumatic hoʻololi i ka maʻi (methotrexate), nonsteroidal anti-inflammatory drugs (naproxen, ibuprofen, celecoxib, meloxicam, a me diclofenac), biologics (certolizumab pegol, secukinumab, infliximab), a biosimilars.
E kiʻi i kope kope o ka hōʻike:
https://www.futuremarketinsights.com/reports/sample/rep-gb-12345
ʻO Ankylosing Spondylitis Treatment Market Landscape
ʻO nā mea pāʻani nui i ka mākeke spondylitis ankylosing ʻo Wyeth, Mitsubishi Tanabe, Schering-Plough, Takeda, Novartis AG, Amgen, Centocor, Abbott, Eisai, a me Pfizer.
E like me ka Oxford University Press, ma kahi o 1% o ka heluna kanaka US, 1.3-1.56 Mn heluna kanaka ʻEulopa, a me 4.63-4.98 Mn heluna kanaka ma Asia Pacific e pili ana i ka ankylosing spondylitis. Eia kekahi, ke ʻike nei ka mākeke i ka hoʻopukapuka nui ma ka ʻaoʻao o ka noiʻi e papa i nā formulations hou.
Ke hāʻawi nui nei nā ʻāpana ulu inorganic i ka ulu ʻana o ka mākeke lapaʻau ankylosing spondylitis. No ka laʻana - Novartis AG, i Jan 2019, i komo i kahi hui pū me TrialSpark me ka pahuhopu o ka hoʻonui ʻana i ke komo ʻana o nā mea maʻi i nā hoʻokolohua lapaʻau. Manaʻo ʻia e pōkole ka manawa kākau inoa, e wikiwiki ai ka hoʻomohala ʻana i nā lāʻau lapaʻau hou.
I ʻOkakopa 2019, ua ʻae ke Komisina ʻEulopa iā Cosentyx e mālama i ka non-radiographic axial spondyloarthritis. ʻO ka hana aʻe e pili ana i ka hoʻouna ʻana i ka palapala noi hōʻailona i ka US FDA a me ka ʻae ʻana ma hope, ke manaʻo nei e ulu nui ka mākeke.
ʻO "Agreement" ka papahana ʻē aʻe i hoʻohana ʻia. No ka laʻana - Izana Bioscience, i Dec 2017, i komo i loko o kahi palapala laikini honua me Takeda Pharmaceutical Company no ka hana ʻana, kālepa, a me ka hoʻomohala ʻana iā Namilumab e mālama i ka spondylitis ankylosing.
Eia kekahi, ua hoʻokumu ʻo Zydus Cadila, i Nov 2017, i ka biosimilar o Adalimumab ma India. Ua hoʻohana ʻia e mālama i ka ankylosing spondylitis, rheumatoid arthritis, juvenile idiopathic arthritis.
ʻO nā hana e like me kēia ke hāʻawi nei i ka impetus i ka mākeke spondylitis ankylosing a ʻo ke kūlana quo e mau nō ia i ka wā wānana.
E noi i kahi TOC piha o kēia hōʻike me nā helu: https://www.futuremarketinsights.com/toc/rep-gb-12345
ʻO nā mea nui mai ka Ankylosing Spondylitis Treatment Market Study
- ʻO nā lāʻau anti-inflammatory nonsteroidal e alakaʻi i ka mākeke e like me ka mea i ʻike ʻia ʻo ia ka lālani mua o ka mālama ʻana no ka ankylosing spondylitis.
- ʻO ke ala waha o ka hoʻokele e paʻa i ka māhele mākeke nui loa ma muli o ka maʻalahi o ka hoʻohana.
- Ma ka pūʻulu makahiki, hāʻawi ka "ʻelemakule" i ka hapa nui o ka loaʻa kālā ma muli o ka hoʻomaka ʻana o ka ankylosing spondylitis i ka wā makua.
- ʻO ʻAmelika ʻAmelika, i alakaʻi ʻia e ka US, e paʻa i ka māhele mākeke kiʻekiʻe loa ma muli o ka hoʻokumu ʻana i ka ʻoihana mālama olakino, nā kiʻekiʻe kiʻekiʻe o ka ankylosing spondylitis, a me nā hana hou i ka ʻoihana lāʻau.
E nīnau iā mākou i kāu mau nīnau e pili ana i kēia hōʻike:
https://www.futuremarketinsights.com/ask-question/rep-gb-12345
Makemake ʻoe i nā ʻike hou aʻe?
Hoʻopili ʻia ka mākeke lapaʻau ankylosing spondylitis honua ma ke kumu o ka papa lāʻau (Nonsteroidal Anti-inflammatory Drugs, Anti-Inflammatory Drugs, Immunosuppressive Drugs, TNF Blockers, JAK Inhibitors, Steroids, Biologics, a me nā mea ʻē aʻe), ke ala o ka hoʻokele (parenteral, waha. ), palapala noi (Nā makua, ʻōpio), a me ka palapala honua (ʻAmelika ʻĀkau, ʻAmelika Latina, ʻEulopa, Asia Hikina, Asia Hema, Oceania, MEA).
Māhele kī
Kōpana Drug
- Nonsteroidal Anti-inflammatory Drugs
- Nā Laʻau Hoʻomāmā
- Nā Laʻau Immunosuppressive
- Nā mea pale TNF
- ʻO nā mea pale JAK
- Nā Steroids
- Nā Biologics
- kekahi
Ke ala o ka hoʻokele
noi
Māhele
- North America
- Lakina Amerika
- ʻEulopa
- ʻO Asia Hikina
- ʻO Kona Hema
- Oceania
- Waena Hikina a me ʻApika
About Ka Makahiki Hou (FMI)
ʻO ka Future Market Insights (ESOMAR i hōʻoia ʻia i ka ʻoihana noiʻi mākeke a me kahi lālā o Greater New York Chamber of Commerce) hāʻawi i nā ʻike hohonu i nā kumu hoʻokele e hoʻokiʻekiʻe ana i ka noi ma ka mākeke. Hōʻike ia i nā manawa kūpono e makemake ai i ka ulu ʻana o ka mākeke ma nā ʻāpana like ʻole ma ke kumu o Source, Application, Sales Channel a me ka hoʻohana hope ʻana i nā makahiki 10 e hiki mai ana.
Kāhea iā mā˚ou:
Nā Hōʻikeʻike o ka Makahiki Hou
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A
ʻO Jumeirah Lakes Towers, Dubai
Aupuni ʻEmira ʻAlapia Hui Pū ʻia
He aha e lawe ʻia mai kēia ʻatikala:
- E pili ana i ka Future Market Insights (FMI)Future Market Insights (ESOMAR i hōʻoia ʻia i ka hui noiʻi mākeke a me kahi lālā o Greater New York Chamber of Commerce) hāʻawi i nā ʻike hohonu i nā kumu hoʻokele e hoʻokiʻekiʻe ana i ka noi ma ka mākeke.
- ʻO nā hana e like me kēia ke hāʻawi nei i ka impetus i ka mākeke spondylitis ankylosing a ʻo ke kūlana quo e mau nō ia i ka wā wānana.
- Hoʻopili ʻia ka mākeke lapaʻau ankylosing spondylitis honua ma ke kumu o ka papa lāʻau (Nonsteroidal Anti-inflammatory Drugs, Anti-Inflammatory Drugs, Immunosuppressive Drugs, TNF Blockers, JAK Inhibitors, Steroids, Biologics, a me nā mea ʻē aʻe), ke ala o ka hoʻokele (parenteral, waha. ), palapala noi (Nā makua, ʻōpio), a me ka palapala honua (ʻAmelika ʻĀkau, ʻAmelika Latina, ʻEulopa, Asia Hikina, Asia Hema, Oceania, MEA).